advertisement
Yamada-Nakanishi Y 17
Showing records 1 to 17 | Display all abstracts from Yamada-Nakanishi Y109698 Detection of Relative Afferent Pupillary Defect and Its Correlation with Structural and Functional Asymmetry in Patients with Glaucoma Using Hitomiru, a Novel Hand-Held Pupillometer
Nakamura M
Journal of clinical medicine 2023; 12:
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Inatani M
Advances in Therapy 2023; 40: 4074-4092
109734 Test-retest repeatability of the imo binocular random single-eye test and Humphrey monocular test in patients with glaucoma
Toyokuni H; Sakamoto M
Japanese Journal of Ophthalmology 2023; 67: 578-589
109698 Detection of Relative Afferent Pupillary Defect and Its Correlation with Structural and Functional Asymmetry in Patients with Glaucoma Using Hitomiru, a Novel Hand-Held Pupillometer
Sakamoto M
Journal of clinical medicine 2023; 12:
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Orii Y; Iwasaki K
Advances in Therapy 2023; 40: 4074-4092
109734 Test-retest repeatability of the imo binocular random single-eye test and Humphrey monocular test in patients with glaucoma
Ueda K
Japanese Journal of Ophthalmology 2023; 67: 578-589
109698 Detection of Relative Afferent Pupillary Defect and Its Correlation with Structural and Functional Asymmetry in Patients with Glaucoma Using Hitomiru, a Novel Hand-Held Pupillometer
Ueda K
Journal of clinical medicine 2023; 12:
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Arimura S
Advances in Therapy 2023; 40: 4074-4092
109698 Detection of Relative Afferent Pupillary Defect and Its Correlation with Structural and Functional Asymmetry in Patients with Glaucoma Using Hitomiru, a Novel Hand-Held Pupillometer
Okuda M
Journal of clinical medicine 2023; 12:
109734 Test-retest repeatability of the imo binocular random single-eye test and Humphrey monocular test in patients with glaucoma
Kurimoto T
Japanese Journal of Ophthalmology 2023; 67: 578-589
109698 Detection of Relative Afferent Pupillary Defect and Its Correlation with Structural and Functional Asymmetry in Patients with Glaucoma Using Hitomiru, a Novel Hand-Held Pupillometer
Takano F
Journal of clinical medicine 2023; 12:
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Sunagawa H
Advances in Therapy 2023; 40: 4074-4092
109734 Test-retest repeatability of the imo binocular random single-eye test and Humphrey monocular test in patients with glaucoma
Yamada-Nakanishi Y; Yamada-Nakanishi Y
Japanese Journal of Ophthalmology 2023; 67: 578-589
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Shiokawa M
Advances in Therapy 2023; 40: 4074-4092
109698 Detection of Relative Afferent Pupillary Defect and Its Correlation with Structural and Functional Asymmetry in Patients with Glaucoma Using Hitomiru, a Novel Hand-Held Pupillometer
Yamada-Nakanishi Y; Yamada-Nakanishi Y
Journal of clinical medicine 2023; 12:
109734 Test-retest repeatability of the imo binocular random single-eye test and Humphrey monocular test in patients with glaucoma
Nakamura M
Japanese Journal of Ophthalmology 2023; 67: 578-589
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Inoue K; Sakono T; Sakono T; Kuwamura R; Yoshida A; Oi J; Kuwayama Y; Kano K; Kido N; Matsuyama A; Ozaki M; Abe H; Inoue C; Nakagawa S; Musashi K; Kanamori A; Lee J; Otani S; Aoki R; Tanabe H; Nakakura S; Suzuki K; Sagara T; Saito Y; Sameshima M; Urahashi M; Watanabe-Kitamura F; Inoue T; Kagaya F; Murai Y; Mori S; Ueda K; Kurimoto T; Yamada-Nakanishi Y; Yamada-Nakanishi Y; Nakamura M; Yamashita T; Ishiyama S; Manabe S; Takaki K; Hayashi K; Ishida A; Tsutsui A; Tsutsui A; Manabe K; Tanito M
Advances in Therapy 2023; 40: 4074-4092